Adv Ther (2017) 34:2033–2042 DOI 10.1007/s12325-017-0593-9 ORIGINAL RESEARCH Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study Mark Fajgenbaum Ejaz Ansari Received: May 28, 2017 / Published online: July 19, 2017 Springer Healthcare Ltd. 2017 40–95 years). Mean length of follow-up was ABSTRACT 56 months (range 24–180 months). Pros- taglandin analogues (PGA) were the most pop- Introduction: The purpose of this study was to ular ﬁrst-line treatment in 73% of patients. As determine prescribing trends in a specialist second-line treatment, PGA were again the glaucoma clinic in the UK. Speciﬁcally, the aims predominant class, prescribed in 87% of cases, were to determine which drugs were prescribed whereas beta-blockers (BB) were prescribed in as ﬁrst-, second-, and third-line treatment, the 70% of cases. Carbonic anhydrase inhibitors persistence of ﬁrst-, second-, and third-line (CAI) and alpha-2 agonists (AA) were more treatment regimens, and the proportion of popular in third-line regimens. Second-line treatment decisions conforming to the Euro- treatment was introduced at a mean of pean Glaucoma Society (EGS) guidelines. 28.0 months after ﬁrst-line treatment (range Methods: A retrospective, non-interventional, 1–120 months, 95% CI 22.1–33.9 months). single-center, case-note review was performed Third-line treatment was
Advances in Therapy – Springer Journals
Published: Jul 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera